OMER (Omeros) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OMER Omeros Corp OMER
26 GF Score
Price $19.27
! 6 Warning Signs
View Full Analysis

What is Omeros Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

OMER
26GF Score
Omeros Corp OMER
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omeros Business Description

Other Exchanges 0KBU:UK3O8:Germany
Address 201 Elliott Avenue West, Seattle, WA, USA, 98119
Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediated diseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program.
26GF Score

Get the complete analysis for OMER

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.27
Price